Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypercapnia Clinical Efficacy by NIPPV v HVNI: A Randomized Control Trial in the Stabilization of Acute Hypercarbic Respiratory Failure

NCT04709562 is registered in ClinicalTrials.gov with Vapotherm, Inc. as lead sponsor.

NCT NCT04709562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04709562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypercapnia Clinical Efficacy by NIPPV v HVNI: A Randomized Control Trial in the Stabilization of Acute Hypercarbic Respiratory Failure
Lead sponsor
Vapotherm, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2020
Completion date
June 22, 2023
Enrollment
68 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, dyspnea, hypercapnic acidosis, hypercapnic respiratory failure